| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | -197.1MM | -296% |
| Gross Profit | -60MM | -316% |
| Cost Of Revenue | 75.4MM | +3% |
| Operating Income | 12.7MM | -15% |
| Operating Expenses | -72.7MM | - |
| Net Income | 11.6MM | -1% |
| G&A | 13.1MM | +5% |
| Amortization | 1.3MM | +30% |
| Interest Expense | 754K | -19% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Headwaters Capital Management, an investment management company, released its first-quarter 2024 investor letter. A copy of the investor letter can be downloaded here. The fund increased by +10.6% (+10.4% net) in the first quarter compared to a +8.6% return for the Russell Mid Cap Index. During Q1, large caps, led by the S&P 500 with […]
Buying shares in the best businesses can build meaningful wealth for you and your family. While not every stock...
Veteran Industry Executive Brings More Than 35 Years of Corporate Strategy ExperienceDURHAM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced the appointment of Marc D. Kozin as the newest member of the Company’s Board of Directors. In addition, Patrick Machado has announced his retirement from the Chimerix Board effe
NEWBURYPORT, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT) an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate in the upcoming KeyBanc Capital Markets 4th Annual Life Sciences and MedTech Investor Forum to be held virtually on March 19 and 20, 2024.
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Investors in UFP Technologies, Inc. ( NASDAQ:UFPT ) had a good week, as its shares rose 9.0% to close at US$211...
UFP Technologies ( NASDAQ:UFPT ) Full Year 2023 Results Key Financial Results Revenue: US$400.1m (up 13% from FY 2022...
NEWBURYPORT, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of engineered solutions primarily for the medical market, today reported net income of $44.9 million or $5.83 per diluted common share outstanding for its year ended December 31, 2023, compared to net income of $41.8 million or $5.45 per diluted common share outstanding for 2022. Net sales for 2023 were $400.1 million, 13.1% higher than 2022 sales of $353.8 million. For
UFP Technologies (NASDAQ:UFPT) has had a great run on the share market with its stock up by a significant 14% over the...
NEWBURYPORT, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the appointment of Mitchell Rock as President of the Company. Rock has been serving as President of the Company’s MedTech business. R. Jeffrey Bailly will continue in his capacity as Chairman and Chief Executive Officer. “Mitch has been an extremely valuab